xenon gas
DrugInhalation via endotracheal tube of 50% xenon for 18 hours, including during transport for outborn babies, starting within 5 hours after birth.
Other names: LENOXe
NCT Number: NCT02071394
This study examines the effect of inhaled xenon gas in the treatment of newborn infants with hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard treatment for this condition. The hypothesis is that the xenon + cooling combination will produce better neuroprotection than the standard treatment of cooling alone.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
St Michael's Hospital, Bristol, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Infants will be eligible for for the trial if the St Michael's hospital standard inclusion criteria for cooling and additional inclusion criteria for xenon administration are met.
St Michael's hospital standard inclusion criteria for standard hypothermia treatment of 72 hrs:
A: Neonates born at greater than 36 weeks gestation (estimated or clinical assessment) with at least ONE of the following:
If the infant meets criterion A then assess for neurological abnormality using criterion B and C (by trained personnel):
B: Moderate or Severe encephalopathy as evidenced by any of the following:
And
C: At least 30 minutes duration of amplitude-integrated electroencephalography (aEEG) recording that shows abnormal background aEEG activity. The decision to cool is based on the worst 30 min section of the aEEG, not the best [35] or seizures (clinical or electrical) thus meeting ONE of the following:
Additional inclusion criteria for xenon:
Before being considered for additional inhaled xenon therapy via the breathing gas mixture, the infant would need to meet further additional entry criteria (all must be met):
Exclusion criteria
for cooling in the CoolXenon3 study:
Inhalation via endotracheal tube of 50% xenon for 18 hours, including during transport for outborn babies, starting within 5 hours after birth.
Other names: LENOXe
Cooling of baby to reduce rectal temperature to 33.5 degree Centigrade(standard treatment), including during transport for outborn babies, starting within 3 hours after birth.
Other names: Therapeutic hypothermia
Time frame: 18 months of age
Cognition, language and motor scores, hearing and vision
Time frame: Before hospital discharge, within 2 weeks of birth
Magnetic Resonance Imaging findings at less than 2 weeks of age
Time frame: Before hospital discharge, usually within 1 week of birth
Number of hours after birth when aEEG voltage has reached a normal or discontinuous normal pattern
Time frame: 18-24 months
Bayley III composite score ≥ 85 and no neurosensory disability as described above
University Hospitals Bristol and Weston NHS Foundation Trust
Other
Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth: A Randomised Pilot Outcomes Study (COOLXENON3 Study)
Acronym: CoolXenon3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01545271
Body Temperature Changes, Brain Diseases
Bristol, Avon, United Kingdom
View Trial DetailsNCT00934700
Brain Diseases, Brain Ischemia
London, United Kingdom
View Trial DetailsNCT02800018
Brain Diseases, Brain Ischemia
Zurich, Switzerland
View Trial DetailsNCT04217551
Body Temperature Changes, Brain Diseases
Birmingham, Alabama, United States
View Trial Details